- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 495/14 - Ortho-condensed systems
Patent holdings for IPC class C07D 495/14
Total number of patents in this class: 1156
10-year publication summary
78
|
77
|
98
|
100
|
96
|
88
|
85
|
87
|
82
|
63
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Dana-Farber Cancer Institute, Inc. | 2558 |
51 |
Merck Patent GmbH | 5873 |
47 |
FUJIFILM Corporation | 29295 |
35 |
Bristol-myers Squibb Company | 4879 |
23 |
Sumitomo Chemical Company, Limited | 9031 |
23 |
Vanderbilt University | 1894 |
23 |
Duk San Neolux Co., Ltd. | 645 |
20 |
Genentech, Inc. | 3979 |
15 |
Incyte Holdings Corporation | 651 |
15 |
F. Hoffmann-La Roche AG | 7934 |
13 |
The Regents of the University of Michigan | 4676 |
13 |
Hoffmann-La Roche Inc. | 3404 |
12 |
Boehringer Ingelheim International GmbH | 4697 |
12 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2842 |
12 |
C4 Theraprutics, Inc. | 56 |
12 |
Samsung Electronics Co., Ltd. | 145025 |
11 |
LG Chem, Ltd. | 17594 |
11 |
The University of Tokyo | 4168 |
11 |
Novartis AG | 10886 |
10 |
Idemitsu Kosan Co., Ltd. | 4208 |
10 |
Other owners | 777 |